Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Weight & Measure
Also in Medicine
Health & Fitness
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
Today: #159 in Health & Fitness, India on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Psychopharmacology and Psychiatry…, try…
Beyond Well with Sheila Hamilton
Also in Medicine
Docs Who Lift
Also in Medicine
Fat Science
Also in Medicine
The Dr Louise Newson Podcast
Also in Medicine
Practical Neurology Podcast
Also in Medicine
Ranking history · United States
No ranking history for this show in United States over the last 14 days.
Latest episodes
-
First-Episode Psychosis in Women
October 28, 2026 · 12 minFaculty: Amanda Koire, M.D., Ph.D. Host: Flavio Guzmán, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 87 First-Episode Psychosis in Women: Which Antipsychotic Is the Preferred Choice?
-
Second-Generation Antipsychotics for OCD Augmentation
October 23, 2026 · 10 minFaculty: Robert Hudak, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation Second-Generation Antipsychotics for OCD Augmentation: Third-Line Agents
-
Are Z-Drugs Safe in the First Trimester of Pregnancy?
October 18, 2026 · 18 minIn this episode, we review a JAMA Psychiatry study of over 4 million pregnancies examining first-trimester Z-drug exposure and congenital malformations. Dr. Amanda Koire explains why overall risk wasn't increased, what the neural tube…
-
Glutamatergic Augmentation in OCD
October 13, 2026 · 16 minFaculty: Robert Hudak, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation Glutamatergic Augmentation in OCD: Memantine, Riluzole, Lamotrigine and Other…
-
Schizophrenia: Which of Seven Antipsychotics Wins?
October 9, 2026 · 15 minFaculty: Oliver Freudenreich, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 0.75 CMEs: Quick Take Vol. 85 Schizophrenia: Which of Seven Antipsychotics Wins on Acute Efficacy and Safety?
Show 7 more episodesShow fewer episodes
-
SSRI Dosing for OCD: Beyond FDA Guidelines
October 3, 2026 · 9 minFaculty: Robert Hudak, M.D. Host: Flavio Guzmán, M.D. Learn more about our memberships here Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines Treatment-Resistant OCD: From SSRIs to Augmentation
-
Trazodone for Insomnia and Comorbid Depression
September 28, 2026 · 11 minIn this episode, we explore a new meta-analysis reconciling trazodone's real-world reputation with cautious sleep medicine guidelines, examining its effects on sleep architecture and depressive symptoms in patients with comorbid insomnia…
-
Antipsychotics, Prolactin, and Sexual Side Effects
September 23, 2026 · 9 minIn this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr. Oliver Freudenreich breaks down which medications carry the highest risk, the long-term…
-
EMERGENT-5: Cobenfy and Treatment Durability
September 18, 2026 · 13 minIn this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side…
-
Antipsychotics and Weight Gain
September 13, 2026 · 15 minIn this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — why it happens, which medications carry the highest risk, and how to build a proactive ABC strategy using switching, metformin, and…
-
EPA vs. DHA: Fish Oil and Treatment-Resistant Depression
September 8, 2026 · 13 minIn this episode, we explore whether EPA, a specific omega-3 fatty acid, can help patients with treatment-resistant depression. Dr. Derick Vergne breaks down the clinical evidence, dosing, and the anti-inflammatory mechanisms that may…
-
AUD Medications and Hepatic Safety
September 3, 2026 · 10 minIn this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin Sevarino breaks down a practical algorithm for selecting between naltrexone, acamprosate, disulfiram, and other options, tailored to…
About the show
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.